Polar Asset Management Partners Inc. Trims Position in Alphatec Holdings, Inc. $ATEC

Polar Asset Management Partners Inc. lessened its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 93.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,718 shares of the medical technology company’s stock after selling 198,526 shares during the period. Polar Asset Management Partners Inc.’s holdings in Alphatec were worth $139,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Comerica Bank raised its holdings in shares of Alphatec by 66.8% during the 4th quarter. Comerica Bank now owns 3,116 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 1,248 shares during the period. Oppenheimer Asset Management Inc. raised its holdings in shares of Alphatec by 13.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,144 shares of the medical technology company’s stock worth $133,000 after acquiring an additional 1,552 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Alphatec by 4.6% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 40,734 shares of the medical technology company’s stock worth $413,000 after acquiring an additional 1,792 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Alphatec by 3.2% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,809 shares of the medical technology company’s stock worth $650,000 after acquiring an additional 2,177 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Alphatec by 38,433.3% during the 1st quarter. GAMMA Investing LLC now owns 2,312 shares of the medical technology company’s stock worth $228,000 after acquiring an additional 2,306 shares during the period. Hedge funds and other institutional investors own 66.35% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ATEC shares. Wall Street Zen upgraded Alphatec from a “hold” rating to a “buy” rating in a report on Sunday. Canaccord Genuity Group restated a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a report on Friday, August 1st. Barclays restated an “overweight” rating and issued a $22.00 price objective (up from $21.00) on shares of Alphatec in a report on Monday, August 4th. Finally, Lake Street Capital upgraded shares of Alphatec to a “buy” rating and set a $18.00 price objective on the stock in a report on Monday, June 16th. Six investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $18.50.

Alphatec Stock Down 0.9%

Shares of ATEC opened at $16.40 on Friday. The firm has a market cap of $2.43 billion, a P/E ratio of -14.51 and a beta of 1.02. The company has a current ratio of 2.88, a quick ratio of 1.77 and a debt-to-equity ratio of 23.22. The company’s 50-day moving average price is $13.38 and its 200 day moving average price is $11.92. Alphatec Holdings, Inc. has a 12-month low of $4.88 and a 12-month high of $16.70.

Alphatec (NASDAQ:ATEC) last released its earnings results on Thursday, July 31st. The medical technology company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.08. The company had revenue of $185.54 million during the quarter, compared to the consensus estimate of $178.85 million. Alphatec had a negative return on equity of 1,657.19% and a negative net margin of 24.33%.Alphatec’s revenue was up 27.5% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.29) EPS. Alphatec has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current year.

Insider Transactions at Alphatec

In other Alphatec news, General Counsel Tyson Eliot Marshall sold 18,092 shares of Alphatec stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $14.91, for a total value of $269,751.72. Following the completion of the transaction, the general counsel directly owned 438,331 shares of the company’s stock, valued at $6,535,515.21. The trade was a 3.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Craig E. Hunsaker sold 50,000 shares of Alphatec stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $15.00, for a total value of $750,000.00. Following the completion of the transaction, the executive vice president directly owned 1,400,018 shares of the company’s stock, valued at approximately $21,000,270. This represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 510,247 shares of company stock valued at $7,627,527. 20.90% of the stock is owned by insiders.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.